متابعة
Mehmet Sofuoglu
Mehmet Sofuoglu
بريد إلكتروني تم التحقق منه على yale.edu
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
The effect of cannabis compared with alcohol on driving
RA Sewell, J Poling, M Sofuoglu
American journal on addictions 18 (3), 185-193, 2009
5202009
Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
M Sofuoglu, PS Portoghese, AE Takemori
The Journal of pharmacology and experimental therapeutics 257 (2), 676-680, 1991
4531991
Cognitive enhancement as a treatment for drug addictions
M Sofuoglu, EE DeVito, AJ Waters, KM Carroll
Neuropharmacology 64, 452-463, 2013
3732013
Stress decreases the ability to resist smoking and potentiates smoking intensity and reward
SA McKee, R Sinha, AH Weinberger, M Sofuoglu, ELR Harrison, ...
Journal of psychopharmacology 25 (4), 490-502, 2011
3492011
Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans.
M Sofuoglu, S Dudish-Poulsen, D Nelson, PR Pentel, DK Hatsukami
Experimental and clinical psychopharmacology 7 (3), 274, 1999
3231999
Neuroscience of behavioral and pharmacological treatments for addictions
MN Potenza, M Sofuoglu, KM Carroll, BJ Rounsaville
Neuron 69 (4), 695-712, 2011
2822011
Cognitive effects of nicotine: recent progress
G Valentine, M Sofuoglu
Current neuropharmacology 16 (4), 403-414, 2018
2702018
Norepinephrine and stimulant addiction
M Sofuoglu, RA Sewell
Addiction biology 14 (2), 119-129, 2009
2412009
Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population
J Poling, A Oliveto, N Petry, M Sofuoglu, K Gonsai, G Gonzalez, B Martell, ...
Archives of general psychiatry 63 (2), 219-228, 2006
2342006
The drug effects questionnaire: psychometric support across three drug types
ME Morean, H de Wit, AC King, M Sofuoglu, SY Rueger, SS O’Malley
Psychopharmacology 227, 177-192, 2013
2292013
Cognitive enhancement as a pharmacotherapy target for stimulant addiction
M Sofuoglu
Addiction 105 (1), 38-48, 2010
1942010
Novel approaches to the treatment of cocaine addiction
M Sofuoglu, TR Kosten
CNS drugs 19 (1), 13-25, 2005
1672005
Role of progesterone in nicotine addiction: evidence from initiation to relapse.
WJ Lynch, M Sofuoglu
Experimental and clinical psychopharmacology 18 (6), 451, 2010
1632010
Treatment outcome predictors for cocaine dependence
J Poling, TR Kosten, M Sofuoglu
The American journal of drug and alcohol abuse 33 (2), 191-206, 2007
1602007
Sex steroid hormones, stress response, and drug craving in cocaine-dependent women: implications for relapse susceptibility.
R Sinha, H Fox, KI Hong, M Sofuoglu, PT Morgan, KT Bergquist
Experimental and clinical psychopharmacology 15 (5), 445, 2007
1432007
Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study
G Gonzalez, K Sevarino, M Sofuoglu, J Poling, A Oliveto, K Gonsai, ...
Addiction 98 (11), 1625-1632, 2003
1432003
Effects of progesterone treatment on smoked cocaine response in women
M Sofuoglu, DA Babb, DK Hatsukami
Pharmacology Biochemistry and Behavior 72 (1-2), 431-435, 2002
1432002
The impact of cigarette smoking on stimulant addiction
AH Weinberger, M Sofuoglu
The American journal of drug and alcohol abuse 35 (1), 12-17, 2009
1392009
Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine
M Sofuoglu, AI Herman, H Nadim, P Jatlow
Neuropsychopharmacology 37 (6), 1509-1516, 2012
1372012
Effects of progesterone treatment on cocaine responses in male and female cocaine users
M Sofuoglu, E Mitchell, TR Kosten
Pharmacology Biochemistry and Behavior 78 (4), 699-705, 2004
1322004
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20